Dapagliflozin meets primary endpoint in Deliver phase-III trial
Reduces risk of cardiovascular death or worsening heart failure in patients with preserved ejection fraction
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
BD Life Sciences organises roadshows on ‘Advances in Clinical Flow Cytometry’
Organised in Bengaluru, Dhaka, Lucknow and Mumbai, each of the ACFC events enabled discussions by experts from the clinical…
Regrow Biosciences gets US FDA nod for phase-II trials of Ossgrow for Osteonecrosis in US
The company moves one-step closer to attain a global market monopoly estimated at $5 billion through this feat
Zydus Lifesciences Q4 profit declines 41 per cent to Rs 397 crores
Consolidated total revenue from operations during the quarter under review stood at Rs 3,863.8 crores as against Rs 3,670.3 crores…
Akums Drugs receives approval for manufacturing Bempedoic Acid tablets in India
Akum's research and development teams are working on various combinations of Bempedoic plus other molecules, and soon these…
Sun Pharma recalls more than 10,000 bottles of generic anti-depression drug in US
The drug is used to treat depression and prevent Seasonal Affective Disorder (SAD)
Sanofi’s Dupixent wins US approval for bigger use
Sanofi's regulatory filing for EoE is under review by the European Medicines Agency (EMA)
Siga gets requests for smallpox drug in Europe as monkeypox spreads
The drug, approved to treat smallpox in the US and the family of orthopoxvirus that includes monkeypox and cowpox in the EU, has…
India supplies non-J&J vaccines to Cambodia and Thailand under Quad umbrella
The leaders of the Quad countries - India, the US, Japan and Australia - could discuss the vaccine supply plan when they meet in…
Dr Reddy’s Lab to approach regulator for Sputnik Light as booster dose
The Drugs Controller General of India (DCGI) in February granted approval to the single-shot Sputnik Light vaccine for restricted…